Fluoroestradiol F 18 Pregnancy and Breastfeeding Warnings

Brand names: Cerianna

Fluoroestradiol F 18 Pregnancy Warnings

Use should be avoided.

US FDA pregnancy category: Not assigned.

Risk summary:
-All radiopharmaceuticals (including this drug) have the potential to cause fetal harm when administered during pregnancy; data on the use of this drug in pregnant women is not available to inform a drug-related risk.

Comments:
-Assess pregnancy in females of reproductive potential before administering this drug.
-Inform a pregnant woman of the potential risks of radiation to the fetus with the use of this drug.

Animal studies have not been conducted to evaluate the effect of this drug on female reproduction and embryo-fetal development. There are no controlled data in human pregnancy.

US FDA pregnancy category not assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Fluoroestradiol F 18 Breastfeeding Warnings

Avoid breastfeeding for 4 hours after administering this drug.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments:
-The effects in the nursing infant or on milk production are unknown.
-Avoid breastfeeding for 4 hours after administering this drug to reduce radiation exposure to a breastfed infant.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer